Harvard Titles
Adjunct Professor Epidemiology, Harvard T.H. Chan School of Public Health
Lecturer on Medicine, Part-time
Other Affiliations
Channing Division of Network Medicine, Brigham and Women's Hospital
Address
Channing Laboratory
181 Longwood Avenue, 4th Floor, Room 444
Boston, MA 02115
Publications View
Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors [invited review]
Authors: Schernhammer ES, Dittrich CH
Wien Med Wochenschrift
Wien Med Wochenschrift
[Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors].
Insulin-like growth factor and breast cancer risk: evidence from observational studies.
In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor?
Gallstones, cholecystectomy, and the risk for developing pancreatic cancer.
Authors: Schernhammer ES, Michaud DS, Leitzmann MF, Giovannucci E, Colditz GA, Fuchs CS.
Br J Cancer
View full abstract on Pubmed
Br J Cancer
View full abstract on Pubmed
Response: Night shift work, light at night, and risk of breast cancer [editorial]
Authors: Schernhammer ES, Colditz GA
J Natl Cancer Inst
J Natl Cancer Inst
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study.
Authors: Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA.
J Natl Cancer Inst
View full abstract on Pubmed
J Natl Cancer Inst
View full abstract on Pubmed
Docetaxel/cisplatin as first-line therapy in head and neck cancer
Authors: Kienzer H, Schweiger J, Baur M, DeSantis M, Poehnl R, Gerber E, Soucek B, Schernhammer E, Postner G, Pont J, Schlappack A, Schratter-Sehn A, Wicke W, Dittrich CH
Pro ASCO
Pro ASCO
Intra-individual dose escalation with carboplatin/mitomycin C in advanced breast cancer
Authors: Kienzer H, Baur M, Faezeny M, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Point J, Dittrich C
Ann Oncol (Pro ESMO, Athens, Greece)
Ann Oncol (Pro ESMO, Athens, Greece)
First-line therapy in head and neck cancer with docetaxel/cisplatin
Authors: Baur M, Kienzer H, Schweiger J, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Pont J, Schratter-Sehn A, Wicke W, Dittrich CH
Ann Oncol (Pro ESMO, Athens, Greece)
Ann Oncol (Pro ESMO, Athens, Greece)